Likhamphani tse 10 tse holimo ka ho fetisisa tsa China Biotech [Pharma]

E qetetse ho nchafatsoa ka la 7 Loetse 2022 ka 01:28 pm

Mona u ka fumana Lethathamo la Likhamphani tse 10 tse holimo ka ho Fetisisa tsa China Biotech [Pharma] tse nang le Financials, Revenue le Profile ea Khampani ka 'ngoe.

Lethathamo la Likhamphani tse 10 tse ka Holimo-limo tsa China Biotech [Pharma]

Kahoo mona ke Lethathamo la

1. Sehlopha sa Guangzhou Baiyunshan Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. ke khamphani e thathamisitsoeng e laoloang ke Guangzhou Pharmaceutical Group Co., Ltd. (A share 600332, H share 00874), e sebetsanang haholo le:

1. Meriana ea patent ea Machaena le ea Bophirima, thepa e tala ea lik'hemik'hale, meriana ea tlhaho, meriana ea likokoana-hloko, lisebelisoa tsa lik'hemik'hale tsa R&D, tlhahiso le thekiso ea li-intermediates;
2. Morekisi, thekiso le ho kenya le ho romela kantle ho naha ea meriana ea bophirimela, meriana ea setso ea Chaena le lisebelisoa tsa bongaka;
3. R&D, tlhahiso le thekiso ea lihlahisoa tse kholo tsa bophelo bo botle; le
4. Litšebeletso tsa bongaka le tsamaiso ea bophelo bo botle , Tlhokomelo ea bophelo bo botle le penshene le matsete a mang a indasteri ea bophelo bo botle, joalo-joalo. 

Sehlopha se na le kakaretso ea 25 ea meriana lik'hamphani tsa tlhahiso le litsi (ho kenyeletsoa makala a 3, lithuso tse 19 le likhoebo tse kopaneng tse 3), ho kenyeletsoa le 12 e hlomphuoang ka nako ea Machaena. lik'hamphani tse etsang meriana le lik'hamphani tsa 10 lekholong la lilemo; lihlahisoa tse khethehileng tsa meriana ea Machaena Ho na le melaoana e fetang 100 (ho kenyeletsoa ho ts'oara lithuso le likhoebo tse kopaneng).

• Chelete: CNY 79 Billion

Ka mor'a lilemo tsa kaho e hlokolosi le tsoelo-pele e potlakileng, Sehlopha se thehile butle-butle likarolo tse 'nè tse kholo tsa khoebo: "Great Southern Medicine", "Big Health", "Big Business" le "Big Medical", hammoho le "E-commerce", " Capital Finance" le "Medical Devices". "Libopeho tse tharo tse ncha. 

2. Mokhatlo oa Chaena oa Meriana ea Tumellano ea Sechaba

China National Accord Medicines Corporation Ltd. ke k'hamphani e thehiloeng China eo haholo-holo e sebetsanang le khoebo ea ho rekisa ka bongata, ho rekisa le ho e etsa.

Lihlahisoa tsa mantlha tsa Khampani li kenyelletsa litokisetso tsa lithibela-mafu, matla liente, lithibela-mafu Active Pharmaceutical Ingredients (APIs), lithethefatsi tsa tsamaiso ea ho hema le lithethefatsi tsa pelo le cerebrovascular system, har'a tse ling.

• Chelete: CNY 67 Billion

Khampani e boetse e kentse letsoho phanong ea litšebeletso le lits'ebeletso tsa polokelo, lits'ebeletso tsa khiriso le lits'ebeletso tsa koetliso, har'a tse ling. Khampani e aba lihlahisoa tsa eona haholo-holo 'marakeng oa lehae.

3. China National Pharmaceutical

China National Pharmaceutical and Healthcare Industry Co., Ltd. ke khamphani e thathamisitsoeng ke naha e thathamisitsoeng ho Shanghai Stock Exchange ( khutsufatso ea setoko: China National Pharmaceutical; stock code: 600056).

Setsebi se laolang ke China General Technology (Group) Holdings Co., Ltd. Ka motse-moholo o ngolisitsoeng oa li-yuan tse limilione tse likete tse 1.068, khamphani ke e 'ngoe ea likhoebo tse tharo tse bohareng tse nang le indasteri ea meriana joalo ka khoebo ea eona e ka sehloohong.

• Chelete: CNY 56 Billion

Moetapele oa China National Pharmaceutical e ne e le Mokhatlo oa Naha oa China oa Meriana le Lihlahisoa tsa Lihlahisoa tsa Bophelo bo Botle tlas'a Lekala la mehleng la Khoebo ea Kantle le Tšebelisano Moruong ka 1984.

E ne e okametse indasteri ea naha ea meriana le lihlahisoa tsa bophelo tse tsoang kantle ho naha. E ile ea ikopanya le China General Technology Group ka 1999 'me ea e-ba eona feela setsi sa sehlopha ka mor'a ho hlophisoa bocha ha bongaka. thepa ka hare ho sehlopha.

4. Nanjing Pharmaceutical Factory

Nanjing Pharmaceutical Factory Co. Ltd. e qalile ho fumanoa ka 1935 'me e ne e le e mong oa bahlahisi ba bohlokoa ho Indasteri ea Sechaba ea Meriana. Kamora ho hlophisoa bocha ha thepa ke Shenzhen Anyuan Investment Group ka 2000, Nanjing Pharmaceutical Factory e fetoha sehlopha se seholo sa meriana se kopanyang R&D, tlhahiso le papatso ea li-APIs (Active Pharmaceutical Ingredients), litlhare le li-intermediate.

Tsamaiso e ncha e fetola mohala oa sehlahisoa le leano la nts'etsopele ea k'hamphani, ho latela filosofi ea "tlhokomelo ea bophelo, boitlamo ba bophelo bo botle", Nanjing Pharmaceutical Factoty e tla kenya letsoho ho ntlafatsa bophelo le bophelo ba motho tlas'a tataiso ea "liphetoho le bophelo bo botle". popontshwa”.

• Chelete: CNY 39 Billion

Setsi sa tlhahiso ea li-API, se fumanehang Nanjing Chemical Industrial Park, se na le limela tse tšeletseng tsa tlhahiso ho kenyeletsa lithupelo tse khethehileng le tse ngata. Motheo o fetile tlhahlobo ea GMP ea naha le ea machabeng ka makhetlo a mangata. Hoo e ka bang mefuta e mashome a mabeli ea li-API e rekisetsoa limmaraka tsa lapeng le mose ho maoatle.

Motheo oa tlhahiso ea lihlahisoa o fumaneha Nanjing Xingang Economic & Technological Development Zone, e nang le workshop ea liente (antineoplastic agents-based powder and metsi liente) le workshop e tiileng ea ho lokisetsa molomo (matlapa, li-capsules le granules). Motheo o fetile tlhahlobo ea naha ea GMP ka makhetlo a mangata. Mefuta e fetang mashome a mabeli ea litokisetso e rekisoa hohle China.

5. Yunnan Baiyao

Yunnan Baiyao e thehiloe ka 1902, lets'oao le tsebahalang naheng ea China, mme e ne e le e 'ngoe ea lihlopha tsa pele tsa likhoebo tse ncha tsa naha. Ke lebitso le tsebahalang la China le hlomphuoang ka nako lapeng le kantle ho naha.

Ka 1971, fektheri e thehiloe ho latela litaelo tsa Tonakholo Zhou Enlai. Ka 1993, e ne e thathamisitsoe ho Shenzhen Stock Exchange e le k'hamphani ea pele e thathamisitsoeng Yunnan.

• Chelete: CNY 32 Billion
• E thehiloe: 1902

Khampani e arotsoe haholo ka likarolo tse 'ne tse kholo: meriana, lihlahisoa tsa bophelo bo botle, lisebelisoa tsa meriana ea setso ea Chaena, le thepa ea meriana.

Lekala le leng le le leng le ikemetse ebile lea tšehetsana, ho tloha ho tsoalisong, ho lema, ho etsa lipatlisiso le nts'etsopele, ho etsa tlhahiso ho isa Tsamaisong ea boleng ba 'maraka ea lihlahisoa tsohle tse phetseng hantle le lits'ebeletso li theha tikoloho ea moruo le ho kopanngoa ha liindasteri tsa thuto e phahameng le tse molemo ka bobeli. ntshetsopele ya mafapha a mangata.

6. Sehlopha sa Shandong Realcan Pharmaceutical

Shandong Realcan Pharmaceutical Group ke k'hamphani e rekisang lithethefatsi, lisebelisoa tsa bongaka le lisebelisoa tsa bongaka ho litsi tsa bongaka naheng ka bophara. E boetse e na le likarolo tse robeli tse kholo tsa lits'ebeletso ho kenyelletsa theknoloji ea lichelete, meriana ea setso ea Machaena, meriana ea dijithale, barutehi ba meriana, tsamaiso ea litsebi, lisebelisoa tsa R&D le tlhahiso, tlhahlobo ea bongaka, le ho kopanya lisebelisoa. Mofani oa litšebeletso tsa bongaka.

Sehlopha sa Shandong Realcan Pharmaceutical se thehiloe ka la 21 Loetse 2004 ka motse-moholo o ngolisitsoeng oa li-yuan tse limilione tse likete tse 1.5. E na le litšehetso tse fetang 130 le tse fetang 12,000 basebetsi ba. 

• Chelete: CNY 28 Billion
• E thehiloe: 2004
• Basebetsi: 12000

Khampani e ne e thathamisitsoe 'marakeng oa Shenzhen A-share ka Phuptjane 2011 e nang le khoutu ea setoko 002589. Marang-rang a eona a thekiso a akaretsa liprofinse le litoropo tsa 31 ho pholletsa le naha, a sebeletsa ka kotloloho litsi tsa bongaka tse fetang 42,000, mme khoebo ea eona e akaretsa hoo e batlang e le bahlahisi bohle ba malapeng le ba kantle ho naha. boholo bo khethiloeng.

7. Jiangsu Hengrui Pharmaceutical

Jiangsu Hengrui Pharmaceutical Co., Ltd. ke k'hamphani ea meriana le bophelo bo botle e sebetsanang le boqapi ba meriana le R&D ea boleng bo holimo, tlhahiso le papatso.

E thehiloe ka 1970 mme e thathamisitsoe ho Shanghai Stock Exchange ka 2000. Ho ea qetellong ea 2019, e na le basebetsi ba fetang 24,000 lefatšeng ka bophara. Ke morekisi ea tsebahalang oa lapeng oa litlhare tse thibelang hlahala, litlhare tsa ho buoa le li-agent tse fapaneng, hape ke karolo e etellang pele ea National Anti-tumor Drug Technology Innovation Industry-University-Research Alliance.

• Chelete: CNY 26 Billion

E thehile Setsi sa Naha sa Patlisiso ea Theknoloji ea Boenjiniere ba Lithethefatsi e Lebeletsoeng le setsi sa lipatlisiso tsa kamora bongaka. Ka 2019, k'hamphani e fihletse chelete ea ts'ebetso ea li-yuan tse libilione tse 23.29 le lekhetho la li-yuan tse limilione tse likete tse 2.43, 'me ea khethoa lenaneng la TOP50 la lik'hamphani tsa lefats'e tsa meriana, tse maemong a bo47.

Lilemong tsa morao tjena, k'hamphani e tsetetse chelete e ka bang 15% ea thekiso ea eona ho lichelete tsa lipatlisiso le nts'etsopele. Ka 2019, e tsetetse kakaretso ea li-yuan tse limilione tse likete tse 3.9 licheleteng tsa lipatlisiso le nts'etsopele, boikarabello bakeng sa 16.7% ea chelete ea thekiso. 

Khampani e thehile litsi kapa makala a R&D United States, Europe, Japan le China, 'me e ahile sehlopha sa R&D sa batho ba fetang 3,400, ho kenyeletsoa lingaka tse fetang 2,000, masters le batho ba fetang 200 ba khutlileng. Lilemong tsa morao tjena, k'hamphani e entse merero e khethehileng ea naha ea 44, 'me e na le lithethefatsi tse 6 tse ncha, irecoxib, apatinib, thiopefilgrastim, pirotinib, carrelizumab le toluene Remazolam acid e ile ea amoheloa bakeng sa ho rekisoa, sehlopha sa lithethefatsi tse ncha li tlas'a nts'etsopele ea bongaka, le palo ea litlhare tse ncha li ntse li ntlafatsoa United States. 

Khampani e entse kopo ea litokelo tsa litokelo tsa boqapi tsa lehae tse 894, e na le litokelo tse 201 tse sebetsang tsa boiqapelo tsa lehae, le litokelo tse 286 tse lumelletsoeng kantle ho naha tse kang Europe, Amerika le Japane. Theknoloji ea eona ea mantlha ea thepa e hapile likhau tse 2 tsa maemo a bobeli a Naha ea Saense le Theknoloji ea Tsoelopele le Khau e le 'ngoe ea Khauta ea Patent ea China.

8. Sehlopha sa Renfu Pharmaceutical

Renfu Pharmaceutical Group Co., Ltd. e thehiloe ka 1993 mme e thathamisitsoe ho Shanghai Stock Exchange ka 1997 (600079.SH). Kgwebo e Eteletseng Pele ya Indaseteri ya Meriana Profinseng ya Hubei, Indaseteri ya Meriana ya China e Phahameng ka ho Fetisisa ya 100, Kgwebo ya Pontsho ya Botjhaba ya Saense le Thekenoloji.

Khampani e khomarela leano la "ho ba moetapele ho maraka oa meriana segment”, mme e thehile boemo bo ka sehloohong ho diokobatsi tsa lapeng, di-analgesics, balaodi ba pelehi, meriana ya Uyghur le makalana a mang; ka nako e ts'oanang, e nts'etsapele khoebo ea meriana ka mafolofolo mme e ntse e tsoela pele ho khothaletsa ts'ebetso ea machaba. , Ho fihlela R&D ea lefats'e, sebopeho sa mebaraka le indasteri United States le Afrika.

E le "Setsi sa Naha se Amoheloang ke Setsi sa Theknoloji ea Likhoebo" le "Setsi sa Naha se Seholo sa Morero oa Ntlafatso ea Lithethefatsi", khamphani e tsitlallela ho nka R&D e le selelekela sa pele, 'me e ka pele ho matsete a R&D a lik'hamphani tsa lehae tsa meriana le tsoelopele e ncha ea R&D ea lithethefatsi.

E thehiloe ka tšebelisano-'moho le Sekolo sa Machaena sa Setsebi sa Bongaka sa Sesole. Junke Optics Valley Innovative Drug R&D Center” e etelletse pele ho thehoeng ha "Hubei Biomedical Industry Technology Research Institute", e ikemiselitseng ho aha sethala sa lehae se secha sa R&D sa indasteri ea lithethefatsi.

9. Sichuan Kelun Pharmaceutical

Kelun ke sehlopha sa meriana se ikgethileng haholo se nang le lekeno la selemo le selemo la thekiso ya diyuan tse dibilione tse 40. E kenyelletsa Sichuan Kelun Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Research Institute Co., Ltd., Klus Pharma Inc. (Kelun, USA), le KAZ Pharmaceutical Co., Ltd. (Kazakhstan Kelun), Sichuan Kelun Pharmaceutical Trading Co. ., Ltd. le lik'hamphani tse fetang 100 lapeng le kantle ho naha. 

• Chelete: CNY 16 Billion

Ka 2017, Kelun e ile ea beha boemo ba bo-155 har'a lik'hamphani tse 500 tse holimo tsa China, 'me matla a eona a felletseng a behiloe har'a tse tharo tse holimo indastering ea meriana ea China. Ka selemo sa 2018, Kelun o ile a fuoa khau e le 'mampoli a le mong oa boithuto ba khoebo indastering ea tlhahiso ka lebaka la melemo ea eona ea lefats'e ea liente tse ngata. Ka 2020, Kelun o ile a fuoa Khau ea National Technology Innovation Demonstration Enterprise.

Sichuan Kelun Pharmaceutical Co., Ltd. e ile ea thathamisoa ka katleho Shenzhen Stock Exchange ka Phuptjane 2010. Hang ha e phatlalatsoa, ​​Kelun hang-hang o ile a thakhola leano la matsete a liindasteri tse mashome a libilione mme a qala ho kenya ts'ebetsong leano la nts'etsopele ea "lintlafatso tse tharo tse khannoang. , khōlo e ncha”.

10. Chongqing Zhifei Biological Products

Chongqing Zhifei Biological Products Co., Ltd. ("Zhifei" kapa "Khampani" ka bokhutšoanyane) e na le boteng ba eona indastering ea lihlahisoa tsa tlhaho ka 2002. Khampani e fihletse chelete ea ts'ebetso ea RMB10.59 bilione ka 2019 ka tšehetso ea hoo e batlang e le. Basebetsi ba 3,000 ba ipapisitse le chelete ea eona e ngolisitsoeng ea RMB1.6 bilione le kakaretso ea matlotlo a RMB13.6 bilione.

Ka Loetse 2010, Zhifei o ile a thathamisoa ho Shenzhen Stock Exchange (khoutu ea setoko: 300122), ea eba khoebo ea pele ea ente e tsamaisoang ke lekunutu e thathamisitsoeng ho ChiNext. Zhifei e na le litsi tse hlano tseo e leng tsa tsona ka botlalo le lekala le kopaneng la setoko, moo Beijing ZhifeiLvzhu Biopharmaceutical Co., Ltd. le Anhui ZhifeiLongcom Biopharmaceutical Co., Ltd. e leng likhoebo tse ncha tsa theknoloji e phahameng.

• Chelete: CNY 14 Billion

Lihlahisoa tse fumanehang khoebong tsa Khampani li kenyelletsa Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) (Ekear®), Haemophilus Influenzae Type b Vaccine (XiFeiBei®), Group ACYW.₁₃₅ Meningococcal Polysaccharide Vaccine (Menwayc®), Mycobacterium Vaccae for Ente (Vaccae®), Meningococcal Group A le Group C Polysaccharide Conjugate Vaccine (Mening A Con®), le lihlahisoa tse ling tse ikemetseng. Ho sa le joalo, Zhifei ke eena feela ea abang liente tsa Merck Sharp &Dohme(MSD) tse kang HPV4(Gradasil),HPV9(Gradasil 9),5-valent rotavirus vaccine(Rotateq),23-valent Pneumonia vaccine(Pneumovax 23),Hepatitis. Ente (Vaqta).